Literature DB >> 28962867

Ginsenoside Re prevents angiotensin II-induced gap-junction remodeling by activation of PPARγ in isolated beating rat atria.

Bo Zhang1, Xun Cui2, Hong-Hua Jin3, Lan Hong1, Xia Liu1, Xiang Li1, Qing-Gao Zhang4, Li-Ping Liu5.   

Abstract

AIMS: Ginsenoside Re (G-Re), a major ginsenoside in ginseng, has many beneficial pharmacological effects on negative cardiac contractility, electromechanical alternans, antiarrhythmia, angiogenic regeneration and cardiac electrophysiological function. However, effects of G-Re on gap-junction remodeling are unclear. Therefore, this study aimed to investigate the effect of G-Re on angiotensin II (Ang II)-induced downregulation of connexin-40 (CX40) and -43 (CX43) in beating rat left atria. MAIN
METHODS: In this study, the isolated perfused beating rat atrial model was used and atrial gap-junction remodeling was induced by Ang II. In vivo hemodynamic experiments were analyzed with a biological recorder. Changes in protein expression were analyzed by western blot. KEY
FINDINGS: G-Re attenuated Ang II-induced abnormal changes in heart rate, MAP, LVESP, LVEDP, +dp/dt max, -dp/dt min, P wave amplitude, P-R interval and P wave length. This indicated a dose-dependent preventive role against Ang II-induced hyper hemodynamics in rats. Atrial activities of p38 mitogen-activated protein kinase (MAPK), nuclear factor kappa-B (NF-κB) and activator protein 1 (AP-1) were significantly increased by Ang II, as was expression of atrial collagen I and matrix metalloproteinase 2 (MMP2). Atrial CX40 and CX43 expression was downregulated by Ang II. These Ang II-induced atrial effects were blocked by G-Re, as well as rosiglitazone, an agonist of peroxisome proliferator-activated receptor γ (PPARγ), in a dose-dependent manner. However, this inhibition was abolished by the PPARγ inhibitor GW9662. SIGNIFICANCE: G-Re may suppress Ang II-induced downregulation of CX40 and CX43, by activating PPARγ signaling, in isolated perfused beating rat atria.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Angiotensin II; Connexin protein; Gap-junction remodeling; Ginsenoside Re; Peroxisome proliferator-activated receptor γ

Mesh:

Substances:

Year:  2017        PMID: 28962867     DOI: 10.1016/j.lfs.2017.09.027

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  A Strategy for Selecting "Q-Markers" of Chinese Medical Preparation via Components Transfer Process Analysis with Application to the Quality Control of Shengmai Injection.

Authors:  Chunxia Zhao; Huan Liu; Peiqi Miao; Houen Wang; Heshui Yu; Chunhua Wang; Zheng Li
Journal:  Molecules       Date:  2019-05-10       Impact factor: 4.411

2.  Telmisartan cardioprotects from the ischaemic/hypoxic damage through a miR-1-dependent pathway.

Authors:  Maria Consiglia Trotta; Bartolo Ferraro; Antonietta Messina; Iacopo Panarese; Eliana Gulotta; Giovanni Francesco Nicoletti; Michele D'Amico; Gorizio Pieretti
Journal:  J Cell Mol Med       Date:  2019-08-01       Impact factor: 5.310

3.  C‑type natriuretic peptide prevents angiotensin II‑induced atrial connexin 40 and 43 dysregulation by activating AMP‑activated kinase signaling.

Authors:  Da-Zhi Ding; Ya-Nan Jia; Bo Zhang; Cheng-Ming Guan; Shuai Zhou; Xiang Li; Xun Cui
Journal:  Mol Med Rep       Date:  2019-10-15       Impact factor: 2.952

4.  The atlas of ACE2 expression in fetal and adult human hearts reveals the potential mechanism of heart-injured patients infected with SARS-CoV-2.

Authors:  Xiuli Shao; Xiaolin Zhang; Ruijia Zhang; Rongli Zhu; Xiuyang Hou; Weijue Yi; Fengmin Wu; Liying Hao; Rui Feng
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-09       Impact factor: 4.249

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.